May 8 – 10, 2018

Boston, MA

The advent of 3D models has presented a new dimension to cancer research. Despite this enormous potential, concerns related to their utility within discovery and development remain to be addressed before adoption and more importantly, regulatory acceptance is seen.

3D Tissue Models: Oncology will explore the technical and cultural challenges at the crux of your research efforts. Join us to explore the very latest industry-driven insights and data on the application of these systems across in cancer drug research.

What makes this event unique?

  1. A high-quality scientific program dedicated to exploring the applicability of spheroids, organoids, PDX and chip-based platforms in IO and oncology.
  2. A multidisciplinary mix of participants representing consortia, leading scientists and pharmaceutical business leaders
  3. A concerted attempt to provide an ambiance at the conference that encourages interaction, exchange of ideas and networking opportunities among all participants

For more information click here

This was a great scientific meeting and networking opportunity.
It brought together key players in the field to discuss important strategic issues of mutual interest.

Brian R. Berridge, Head, WW Animal Research Strategy, GSK

3D Tissue Models 2016/2017 Meeting Chair

borchure tn